Skip to main content

Table 2 Univariate Cox regression analysis in patients with ESCC

From: Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy

Parameters

OS

PFS

HR

95% CI

p value

HR

95% CI

p value

Clinical parameters

   

Age (years)

0.986

0.958–1.016

0.361

0.985

0.956–1.015

0.328

Sex

      

 Male

1

  

1

  

 Female

0.821

0.255–2.642

0.741

0.763

0.238–2.451

0.650

Histologic differentiation grade

 

0.964

 

0.988

 

 Poor

1

  

1

  

 Moderate

0.956

0.648–1.412

0.822

0.977

0.581–1.643

0.931

 Well

1.025

0.701–1.499

0.898

0.935

0.383–2.287

0.884

Tumor location

 

0.006

 

0.011

 

 Upper

1

  

1

  

 Middle

1.450

0.804–2.616

0.217

1.333

0.739–2.402

0.340

 Lower

2.892

1.491–5.612

0.002

2.654

1.375–5.122

0.004

Clinical T stage

 

0.165

 

0.082

 

 T1

1

  

1

  

 T2

1.027

0.417–2.528

0.954

1.006

0.409–2.476

0.989

 T3

2.050

0.851–4.939

0.109

2.163

0.894–5.236

0.087

 T4

1.611

0.691–3.759

0.270

1.857

0.792–4.353

0.154

Clinical N stage

 

0.824

 

0.896

 

 N1

1

  

1

  

 N2

1.027

0.580–1.820

0.927

0.901

0.506–1.602

0.722

 N3

1.252

0.588–2.665

0.560

1.034

0.487–2.196

0.930

AJCC Stage

     

 I–III

1

  

1

  

 IV

1.310

0.801–2.142

0.283

1.366

0.835–2.235

0.214

Chemotherapy

     

 Yes

1

  

1

  

 No

1.267

0.644–2.493

0.492

1.294

0.658–2.544

0.456

PET parameters

     

SUVTumor

1.043

0.999–1.089

0.055

1.054

1.009–1.101

0.019

MTV (cm3)

1.022

1.011–1.033

 < 0.001

1.02

1.01–1.031

 < 0.001

TLG (g)

1.002

1.001–1.004

 < 0.001

1.002

1.001–1.003

 < 0.001

SUVLN

1.025

0.993–1.057

0.129

1.025

0.993–1.057

0.121

PLNS number

1.063

0.993–1.138

0.081

1.037

0.968–1.110

0.304

SDmax(LN-T)(m−1)

6.516

2.427–17.499

 < 0.001

4.972

1.798–13.746

0.002

  1. OS, overall survival; PFS, progression-free survival; HR, hazard ratio; CI, confidence interval; SUVTumor, SUVmax of primary tumor; MTV, metabolic tumor volume; TLG, total lesion glycolysis; SUVLN, SUVmax of lymph node; PLNS, PET positive lymph nodes; SDmax(LN-T), the shortest distance between the farthest PET positive lymph node and the primary tumor in three-dimensional space after the standardization of the patient BSA
  2. Values in bold indicate a significant result (p < 0.1)